Summary
This paper reviews the clinical presentation of 217 patients with urea cycle defects, including 121 patients with neonatal-onset forms and 96 patients with late-onset forms. Long-term outcome of these patients is also reported with the severity of the neonatal forms of these disorders, mostly for ornithine carbamoyltransferase-deficient males. Patients with late-onset forms may present at any age and carry a 28% mortality rate and a subsequent risk of subsequent disabilities.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nassogne, M.C., Héron, B., Touati, G. et al. Urea cycle defects: Management and outcome. J Inherit Metab Dis 28, 407–414 (2005). https://doi.org/10.1007/s10545-005-0303-7
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-0303-7